Thomas McGrath

Tom’s practice focuses on achieving antitrust approval for clients’ most important and complex cross-border M&A transactions, using a pragmatic approach to realize their commercial objectives. Tom also leads the Global U.S. Practice.

Tom has over 25 years’ experience working with clients across a range of sectors, including life sciences, pharmaceuticals, consumer goods, chemicals, engineered products, industrial gases, financial services, transportation, oil & gas and mining. He has served as co-head of Linklaters’ Global Life Sciences Group and Global Chemicals Group.

Tom advises on all aspects of antitrust law, including intellectual property licensing, cooperation with competitors and compliance. He also defends clients in criminal price-fixing investigations and private litigation. Tom regularly appears before the U.S. Department of Justice and Federal Trade Commission on both merger control and litigation matters.

Tom is a member of the Antitrust Section of the American Bar Association and is recognized in Chambers USA. He is recognized in Legal 500 USA and has been named to LawDragon’s 2024 "Top Litigation Lawyers in America." He currently serves as a member of Linklaters’ Partnership Board.